VEGFA and diabetic macular edema: An example of this is Bevasiranib (OPKO Health), a 5-methoxy (CH30) modified siRNA duplex designed to target vascular endothelial growth factor (VEGF), to treat diabetic macular edema or age-related macular degeneration (AMD) [119,120].